Barclays Raises South State PT to $117, Maintains Overweight Rating

Barclays Raises South State PT to $117, Maintains Overweight Rating

Barclays has recently raised its price target for South State Bank (SSB) to $117, while maintaining its Overweight rating. The updated target represents a significant increase from the previous price target of $97.00, reflecting the bank's strong financial performance and growth prospects.

According to the latest financial data, South State Bank is expected to report earnings per share (EPS) of $2.11 in the current quarter (Jun 2025) and $7.98 for the full year (2025). Analysts anticipate revenue of $656.4 million in the next quarter (Sep 2025) and $2.57 billion for the year, reflecting a robust sales growth rate of 51.62% year-over-year.

Barclays' positive outlook is supported by the bank's strong earnings history, with EPS consistently exceeding estimates. In the most recent quarter, South State Bank reported an EPS of $2.15, surpassing the consensus estimate of $1.64. This strong performance, coupled with the bank's solid revenue growth, has led Barclays to revise its price target upward.

Additionally, the bank's recent financial results have shown resilience, with EPS growing by 30.79% year-over-year in the first quarter of 2025. This growth, combined with the bank's solid earnings history and positive analyst revisions, has contributed to Barclays' bullish stance on South State Bank.

Barclays' Overweight rating and $117 price target reflect the bank's strong fundamentals and growth prospects. The bank's solid financial position, coupled with its robust revenue growth and consistent earnings performance, makes it an attractive investment opportunity for investors seeking exposure to the financial sector.

References:
[1] https://www.investing.com/news/analyst-ratings/zealand-pharma-stock-initiated-at-overweight-by-barclays-on-obesity-drug-potential-93CH-4125743
[2] https://finance.yahoo.com/quote/SSB/analysis/